Drug Approval | March 07, 2025
Lupin Launches Rivaroxaban Tablets USP, 2.5mg in US
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
ANVIMO will be available in dosages of 240 mg and 480 mg
This termination of Agreement will not have any significant impact on the company and/or its subsidiaries or its financials
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability
Subscribe To Our Newsletter & Stay Updated
